Navigation Links
A 300 Million Euro Boost for Biomedicine in Berlin
Date:11/13/2012

BERLIN, November 13, 2012 /PRNewswire/ --

Two of Berlin's largest biomedical research centers are merging to form the Berlin Institute of Health (BHI), a joint venture that will receive at least 300 million euros in new funding over the next five years. This makes Berlin an even more significant and attractive research site, not only in the field of biomedicine. This is happening at the right time, for an aging demographic means that there is an increasing demand for health care products and services. Germany Trade & Invest will have experts at this year's MEDICA, the world's largest health fair, from November 14 to 17 to inform visitors about the industry's latest business opportunities.

"The BHI will make Berlin one of the world's top sites for medical excellence and will attract the world's best scientists and junior doctors. The partnership between the Berlin state and federal government has created an exemplary model of cooperation between university and non-university research. Germany has a globally recognized biomedical sector, and it will only improve due to the Institute's innovative models to train medical talent," said Dr. Sandra Bütow, chemical and health expert at Germany Trade & Invest.

Germany is renowned for its effective public-private partnerships such as the Central Innovation Program SME, a country-wide support measure that provides sustainable support to the innovative capabilities and competiveness of small- and medium-sized enterprises. Participants include businesses and researchers from the health and wellness industry who collaborate in order to find innovative and value-added healthcare solutions.

General Electric has also seized on the market opportunity in Germany due to its infrastructure, research and development and changing demographic. Their objective is to powerfully expand its medical division and establish close partnerships with university hospitals.

Germany Trade & Invest is the foreign trade and inward investment agency of the Federal Republic of Germany. The organization advises foreign companies seeking to expand into the German market. It supports German companies that seek to enter foreign markets, with foreign trade information.

Germany Trade & Invest
Andreas Bilfinger
e-mail: andreas.bilfinger@gtai.com
T: +49(0)30-200099-173
http://www.gtai.com/press-subscription
http://twitter.com/gtai_com
http://youtube.com/gtai


'/>"/>
SOURCE Germany Trade and Invest
Copyright©2012 PR Newswire.
All rights reserved

Related biology technology :

1. Avaxia Biologics, Inc. Raises $2.2 Million in First Closing of Series A Financing to Advance Oral Antibodies for Inflammatory Bowel Disease
2. Kansas Bioscience Authority Announces FY11 Outcomes of $207 Million
3. MarketsandMarkets: Global Prostate Cancer Therapeutics Market worth $6,457 Million by 2020
4. Biocartis Completes EUR 71 Million (USD 100 Million) Series C Fund Raising
5. Radius Closes $27.65 Million Second Tranche of Previously Announced Financing
6. BioPower Systems Awarded $5 Million from Victorian Government
7. InnoPharma Completes $15 Million Series A Financing
8. Aratana Therapeutics Completes $15 Million Series B Financing
9. The European Union Signs Grant Contract to Fund a 2 Million Euro Biotechnology Research Project Led by Hadassah College Jerusalem
10. CeNeRx BioPharma Completes $4.85 Million Financing
11. Fox Insurance Company Awarded $3.3 Million in Arbitration Against Former Pharmacy Benefit Manager
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... , June 24, 2016 Epic ... sensitively detects cancers susceptible to PARP inhibitors by ... tumor cells (CTCs). The new test has already ... therapeutics in multiple cancer types. Over ... DNA damage response pathways, including PARP, ATM, ATR, ...
(Date:6/23/2016)... , June 23, 2016   Boston ... of novel compounds designed to target cancer stemness ... has been granted Orphan Drug Designation from the ... treatment of gastric cancer, including gastroesophageal junction (GEJ) ... inhibitor designed to inhibit cancer stemness pathways by ...
(Date:6/23/2016)... 23, 2016  The Prostate Cancer Foundation (PCF) is pleased to ... faster cures for prostate cancer. Members of the Class of 2016 were selected ... Read More About the Class of 2016 PCF Young Investigators ... ... ...
(Date:6/23/2016)... ... ... In a new case report published today in STEM CELLS Translational Medicine, doctors ... being treated for breast cancer benefitted from an injection of stem cells derived from ... frequent side effect of cancer treatment. , Lymphedema refers to the swelling ...
Breaking Biology Technology:
(Date:4/15/2016)... Research and Markets has announced ... 2016-2020,"  report to their offering.  , ... global gait biometrics market is expected to grow ... 2016-2020. Gait analysis generates multiple variables ... to compute factors that are not or cannot ...
(Date:3/31/2016)... , March 31, 2016  Genomics firm Nabsys has ... CEO, Barrett Bready , M.D., who returned to ... the original technical leadership team, including Chief Technology Officer, ... Product Development, Steve Nurnberg and Vice President of Software ... the company. Dr. Bready served as CEO ...
(Date:3/22/2016)... PROVO and SANDY, ... Screening Ontario (NSO), which operates the highest sample volume ... testing, and Tute Genomics and UNIConnect, leaders in clinical ... today announced the launch of a project to establish ... testing panel. NSO has been contracted ...
Breaking Biology News(10 mins):